Biomarkers in Cancer Chemoprevention
| AUTHOR | Bartsch, H.; Boffetta, P.; Boffetta, P. et al. |
| PUBLISHER | World Health Organization (12/31/2001) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value.
This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.
This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.
Show More
Product Format
Product Details
ISBN-13:
9789283221548
ISBN-10:
9283221540
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
English
More Product Details
Page Count:
304
Carton Quantity:
0
Product Dimensions:
6.60 x 0.70 x 9.40 inches
Weight:
1.30 pound(s)
Country of Origin:
CH
Subject Information
BISAC Categories
Medical | Oncology - General
Medical | Public Health
Medical | Epidemiology
Dewey Decimal:
616.992
Library of Congress Control Number:
2001348150
Descriptions, Reviews, Etc.
publisher marketing
The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value.
This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.
This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.
Show More
List Price $42.00
Your Price
$41.58